Prevalence and genotype distribution of cervical human papillomavirus infection in Macao

Journal of Medical Virology

Volumn 82, Issue 10, 2010, Pages 1724-1729

  Yip, Yuk Ching ^a   Ngai, Karry L K ^b   Vong, Heong Ting ^a   Tzang, Lawrence C H ^c,d   Ji, Shenglin ^d   Yang, Mengsu ^c   Chan, Paul K S ^b  

^a Macao Special Administrative Region of the People's Republic of China   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^d Biotech Centre 2   (Hong Kong)

Author keywords

Asia; Cervical cancer; Cervical screening; China; Genotype; Human papillomavirus; Macao; Prevalence

Indexed keywords

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CANCER SCREENING; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; MACAO; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; MACAU; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77956586804     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21826     Document Type: Article

References (38)

1. Chan PK, Chan DP, To KF, Yu MY, Cheung JL, Cheng AF. 2001. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 54:401-403.
2. Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM, To KF, Wong YF, Cheung JL, Chan DP, Hui M, Ip M. 2006. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118:243-245.
3. Chan PK, Ho WC, Wong MC, Chang AR, Chor JS, Yu MY. 2009a. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol 81:1635-1644.
4. Chan PK, Ho WC, Yu MY, Pong WM, Chan AC, Chan AK, Cheung TH, Wong MC, To KF, Ng HK. 2009b. Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades. Int J Cancer 125:1671-1677.
5. Chan PK, Chang AR, Yu MY, Li WH, Chan MY, Yeung AC, Cheung TH, Yau TN, Wong SM, Yau CW, Ng HK. 2010. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer 126:297-301.
6. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003a. Humanpapillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
7. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003b. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
8. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998.
9. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204.
10. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907.
11. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S. 2006. Human papillomavirus infection in Shanxi Province, People's Republic of China: A population-based study. Br J Cancer 95:96-101. (Pubitemid 43980561)
12. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
13. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
14. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. 2004. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13:2271-2276.
15. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N. 2006. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119:2677-2684.
16. Franco EL, Rohan TE, Villa LL. 1999. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91:506-511.
17. FUTURE II Study Group. 2007. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356:1915-1927.
18. Gargiulo F, de Francesco MA, Schreiber C, Ciravolo F, Salinaro F, Valloncini B, Manca N. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 125:176-182.
19. Health Bureau, Macao SAR Government. 2006. Annual report of Macao cancer registry, 2005. http://www.ssm.gov.mo/design/home-e-fs.htm (accessed on Jan25, 2010).
20. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807.
21. Klug SJ, Hukelmann M, Hollwitz B, Düzenli N, Schopp B, Petry KU, Iftner T. 2007. Prevalence ofhumanpapillomavirus types in women screened by cytology in Germany. J Med Virol 79:616-625.
22. Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, Chen CJ. 1997. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408-411.
23. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579-1588.
24. Muñoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19:1-5.
25. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. (Pubitemid 36159887)
26. Muñoz N, Manalastas R, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A. 2009. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11 16, 18) recombinant vaccine in women aged 24-45 years: A randomised, double-blind trial. Lancet 373:1949-1957.
27. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J. 2007. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589-1597.
28. Nielsen A, Kjaer SK, Munk C, Iftner T. 2008. Type-specific HPV infection and multiple HPV types: Prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 35:276-282.
29. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsagué X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamram U, Limson GAM, Dionne M, Quint W, Spiessens B, Peeters P, Struyg F, Wieting SL, Lehtinen MO, Dubin G. 2007. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369:2161-2170.
30. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WAJ, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G. 2009. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 374:301-314.
31. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
32. Schellekens MC, Dijkman A, Aziz MF, Siregar B, Cornain S, Kolkman-Uljee S, Peters LAW, Fleuren GJ. 2004. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 93:49-53.
33. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
34. Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, Chaisuksunt V, Lekawanvijit S, Srisomboon J, Thorner PS. 2008. HPV genotyping in cervical cancer in Northern Thailand: Adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol 108:555-560.
35. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
36. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
37. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S. 2007. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 121:1306-1311.
38. zur Hausen H. 2002. Papillomavirus and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.